Search
for
Sort by
Research 91–120 of 1000+
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- 612 Targeted hair follicle delivery of hydrophilic molecules
- ORAL TARGETED THERAPY-INDUCED CUTANEOUS TOXICITY: LIFE EXPERIENCE OF PATIENTS WITH ADVANCED LUNG CANCER IN TAIWAN
- 855 Targeted deletion of crif1 in mouse skin epidermis impairs skin homeostasis
- 852 Targeted deletion of crif1 in mouse skin epidermis impairs skin homeostasis
- Cutaneous adverse effects of targeted therapies
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Clinical Translation of Targeted Protein Degraders
- Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Dermatologic Reactions to Targeted Therapy
- Isotope Dilution-Based Targeted and Nontargeted Carbonyl Neurosteroid/Steroid Profiling
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Niosomes: A Novel Targeted Drug Delivery System
- Abstract 18: Targeted epidermal ablation of EGFR causes local and systemic inflammation
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- NF-κB in biology and targeted therapy: new insights and translational implications
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- 312 CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- CD44/TRPV1 dual-targeted nanocarrier enables drug retention and multidimensional therapy for inflammatory skin diseases
- PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
- PCA: A tFNA-based targeted nucleic acid nanocomposite hydrogel for the treatment of androgenetic alopecia through the promotion of angiogenesis and hair follicle stem cell proliferation